KLF7

KLF transcription factor 7, the group of Kruppel like factors|Zinc fingers C2H2-type|MicroRNA protein coding host genes

Basic information

Region (hg38): 2:207074136-207173856

Links

ENSG00000118263NCBI:8609OMIM:604865HGNC:6350Uniprot:O75840AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KLF7 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLF7 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
1
clinvar
5
missense
1
clinvar
22
clinvar
1
clinvar
24
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
non coding
1
clinvar
1
Total 0 1 23 4 3

Variants in KLF7

This is a list of pathogenic ClinVar variants found in the KLF7 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-207081229-A-G Inborn genetic diseases Uncertain significance (Mar 05, 2024)3115352
2-207081268-G-A Uncertain significance (May 25, 2022)1703069
2-207088517-G-A Benign (Mar 05, 2018)778017
2-207088525-C-T intellectual deficiency • KLF7-related disorder • Neurodevelopmental disorder • Inborn genetic diseases Pathogenic/Likely pathogenic (Jul 05, 2023)374233
2-207123885-C-A Inborn genetic diseases Uncertain significance (Mar 28, 2023)2530504
2-207123887-C-A Uncertain significance (Oct 12, 2022)2499350
2-207123932-C-G Inborn genetic diseases Uncertain significance (Jan 02, 2024)3115351
2-207123941-G-A Inborn genetic diseases Uncertain significance (Apr 09, 2024)2278844
2-207124020-T-G Uncertain significance (Sep 01, 2019)871305
2-207124052-G-A Inborn genetic diseases Uncertain significance (Nov 13, 2023)3115350
2-207124056-T-C Inborn genetic diseases Uncertain significance (Jan 26, 2022)3115349
2-207124070-C-T Inborn genetic diseases Uncertain significance (May 27, 2022)2351965
2-207124082-G-A Uncertain significance (Apr 08, 2022)1708773
2-207124083-G-T Inborn genetic diseases Uncertain significance (Mar 12, 2024)2270728
2-207124088-G-A KLF7-related neurodevelopmental disorder Uncertain significance (Jan 29, 2024)3238754
2-207124097-G-A Inborn genetic diseases • Delayed gross motor development;Mild expressive language delay • KLF7-related neurodevelopmental disorder • Intellectual disability;Anxiety Conflicting classifications of pathogenicity (Apr 04, 2024)986255
2-207124109-A-C KLF7-related disorder Uncertain significance (Oct 28, 2022)2637281
2-207124114-G-A KLF7-related disorder Likely benign (Sep 05, 2019)3053114
2-207124135-G-A KLF7-related disorder Likely benign (Jan 13, 2020)3051378
2-207124179-G-A Inborn genetic diseases Uncertain significance (Jan 18, 2022)2272058
2-207124205-C-T Inborn genetic diseases Uncertain significance (Jul 20, 2021)2343087
2-207124220-T-G Uncertain significance (Apr 15, 2022)1710574
2-207124241-C-T Inborn genetic diseases Uncertain significance (Aug 15, 2023)2619091
2-207124261-G-A KLF7-related disorder Benign/Likely benign (Mar 14, 2019)789158
2-207124276-T-G Uncertain significance (Jan 09, 2023)2571724

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KLF7protein_codingprotein_codingENST00000309446 493131
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9820.018200000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.301011900.5300.00001201960
Missense in Polyphen1266.120.18149688
Synonymous-1.019583.21.140.00000597609
Loss of Function3.24012.20.006.15e-7146

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcriptional activator. Binds in vitro to the CACCC motif of the beta-globin promoter and to the SP1 recognition sequence.;
Pathway
Adipogenesis (Consensus)

Recessive Scores

pRec
0.121

Intolerance Scores

loftool
0.210
rvis_EVS
-0.43
rvis_percentile_EVS
25.15

Haploinsufficiency Scores

pHI
0.731
hipred
Y
hipred_score
0.600
ghis
0.600

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.904

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Klf7
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;axon guidance;regulation of epidermal cell differentiation;positive regulation of transcription by RNA polymerase II;dendrite morphogenesis;regulation of insulin secretion;negative regulation of adipose tissue development
Cellular component
nucleus
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription coactivator activity;zinc ion binding